Scandinavian Journal of Rheumatology 1997 26:4, 301-307 8 Martin L
In published mouse studies, 50 mg/kg IP twice daily for 28 days is the highest-dose, longest-duration regimen reported in peer-reviewed literature
IMPORTANT PRESCRIBER & PATIENT NOTICE This preparation is compounded only when the prescribing practitioner documents that the FDA-approved product does not meet the patients medical needs (e.g., different strength, excipient profile, or delivery route)
Mechanism Comparison The clearest distinction between BPC-157 and TB-500 is mechanistic
Optional testing available
Khavinson V, Ilina A, Kraskovskaya N et al (2021a) Neuroprotective effects of tripeptidesepigenetic regulators in mouse model of Alzheimers disease